(Q54174685)

English

Development of resistance to imipenem among nosocomial isolates of Pseudomonas aeruginosa.

scientific article published in May 1995

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/7556242

Development of resistance to imipenem among nosocomial isolates of Pseudomonas aeruginosa. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/7556242

Pseudomonas aeruginosa

0 references

author name string

A C Başustaoğlu

1

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/7556242

H Gün

2

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/7556242

M A Saraçli

3

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/7556242

M Baysallar

4

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/7556242

T Haznedaroğlu

5

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/7556242

publication date

1 May 1995

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/7556242

European Journal of Clinical Microbiology & Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/7556242

14

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/7556242

5

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/7556242

469-470

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/7556242

Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone

1 reference

https://api.crossref.org/works/10.1007%2FBF02114909

21 January 2018

In-vitro activity of meropenem, a new carbapenem, against multiresistant Pseudomonas aeruginosa compared with that of other antipseudomonal antimicrobials.

1 reference

https://api.crossref.org/works/10.1007%2FBF02114909

21 January 2018

CDC definitions for nosocomial infections, 1988

1 reference

https://pubmed.ncbi.nlm.nih.gov/7556242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance to imipenem among selected gram-negative bacilli in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/7556242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/7556242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem/cilastatin. A reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7556242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF02114909

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/7556242

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/7556242

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54174685&oldid=2212381169"